Literature DB >> 24362672

Clinical grading of intrahepatic cholestasis pregnancy.

Meena Pradhan1, Yong Shao1.   

Abstract

Intrahepatic cholestasis of pregnancy (ICP) is the pregnancy induced liver disorder causing intense itching of palm, sole or even whole body especially in the evening at late second and third trimester. This disease is categorized into mild and severe ICP according to raised level of LFT including serum level of bile acid and cholic acid. ICP has less morbidity to mother but significant risk to fetus in uterus. The predisposing element to cause intense pruritus is because of high amount of bile acid in maternal serum. Toxic bile acids affect fetal cardiomyocytes retained in fetus body causing sudden intrauterine fetal death. ICP is commonly found in winter months and mostly itching of body occurs in the evening after sunset. Fetus in uterus is unsafe if mother's bile acid exceeds normal value. ICP is successfully treated with Ursodeoxycholic acid (UDCA), S-adenosyl methionine (SAME), Dexamethasone and vitamin K.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362672

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  4 in total

Review 1.  Liver inflammation and fibrosis.

Authors:  Yukinori Koyama; David A Brenner
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

2.  Effect of cholic acid on fetal cardiac myocytes in intrahepatic choliestasis of pregnancy.

Authors:  Hui Gao; Li-Juan Chen; Qing-Qing Luo; Xiao-Xia Liu; Ying Hu; Li-Li Yu; Li Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

Review 3.  Immunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy.

Authors:  Spencer P Larson; Oormila Kovilam; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2015-10-15       Impact factor: 4.473

Review 4.  Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).

Authors:  Xiang Kong; Yan Kong; Fangyuan Zhang; Tingting Wang; Jin Yan
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.